TrialCirculation2019

Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis.

Scott D Solomon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.